Primary malignant lymphoma in the central nervous system treated with high dose methotrexate (MTX)-CHOP (M-CHOP)

Neurological Surgery

Volumn 26, Issue 10, 1998, Pages 889-895

  Matsumoto, Kengo ^a   Maeda, Yasuhiko ^a   Ono, Yasuhiro ^a   Tamiya, Takashi ^a   Furuta, Tomohisa ^a   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Central nervous system; CHOP; Malignant lymphoma; Methotrexate

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLIC ACID; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SCREENING; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; MALE; REMISSION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LEUCOVORIN; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION; VINCRISTINE;

EID: 0031668097     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Berry MP SJ: Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys 7: 55-59, 1981
2. Boiardi A, Silvani A, Valentini S, Salmaggi A, Allegranza A, Broggi G: Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system: preliminary data. J Neurol 241: 96-100, 1993
3. Brada M, Dearnaley D, Horwich A, Bloom HJG: Management of primary cerebral lymphoma with initial chemotherapy: preliminary result and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 18: 787-792, 1990
4. Cellerier P, Chiras J, Gray F, Metzger J, Bories J: Computed tomography in primary lymphoma of the brain. Neuroradiology 26: 485-492, 1984
5. Chamberlain MC, Levin VA: Primary central nervous system lymphoma: a role for adjuvant chemotherapy. J Neurooncol 14: 271-275, 1992
6. DeAngelis L, Yohalom J, Thaler H, Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635-643, 1992
7. Eby NL, Grufferman S, Flannelly CM, Schold SJ, Vogel FS, Burger PC: Increasing incidence of primary brain lymphoma in the US. Cancer 62: 2461-2465, 1988
8. Glass J, Gruber M, Hochberg F: Chemotherapy of primary central nervous system lymphoma (PCNSL) with MCHOD (methotrexate [MTX], cyclophosphamide, adriamycin, vincristine, dexamethasone) prior to radiation therapy. Neurology 43: A209, 1993 (Abstract)
9. Glass J, Gruber ML, Cher L, Hochberg FH: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81: 188-195, 1994
10. Hayakawa T, Takakura K, Abe H, Yoshimoto T, Tanaka R, Sugita K, Kikuchi H, Uozumi T, Hori T, Fukui H, Ushio Y, Nomura K, Matsutani M, Mohri N, Kumanishi T, Aozasa K, Nagashima K: Primary central nervous system lymphoma in Japan: a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan. J Neurooncol 19: 197-215, 1994
11. Helle T, Britt R, Colby T: Primary lymphoma of the central nervous system: clinicopathological study of experience at Stanford. J Neurosurg 60: 94-103, 1984
12. Lachance DH, Brizel DM, Gockerman JP, Halperin EC, Burger PC, Boyko OB, Brown MT, Schold SJ: Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy. Neurology 44: 1721-1727, 1994
13. Letendre L, Banks P, Reese D, Miller R, Scanlon P, Kiely J: Primary lymphoma of central nervous system. Cancer 49: 939-943, 1982
14. Littman P, Wang C: Reticulum cell sarcoma of the brain. Cancer 35: 1412-1420, 1975
15. Matsumoto K, Nakagawa M, Tada E, Furuta F, Hiraki T, Ohmoto T: Effect of adjuvant iridium-192 brachytherapy on the survival of patients with malignant gliomas. Neurol Med Chir (Tokyo) 37: 891-900, 1997
16. McKelvey E, Gottlieb J, Wilson H, Hant A, Talley R, Stephens R, Lane M, Ganble J, Jones S, Grozea P, Gutterman J, Coltman C, Moon T: Hydroxyldaunomycin (adreamycin) combination chemotherapy in malignant lymphoma. Cancer 38: 1484-1493, 1976
17. Neuwelt E, Frenkel E, Grumerlock M, Braziel R, Dana B, Hill S: Developments in the diagnosis and treatment of primary CNS lymphoma: a prospective series. Cancer 58: 1609-1620, 1986
18. Neuwelt EA GD, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel R, Dana B: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580-1590, 1991
19. Pollack IF, Lunsford LD, Flickinger JC, Dameshek HL: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63: 939-947, 1989
20. Shibamoto Y, TK Dodo Y, Yamabe H, Shima N, Abe M: Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 65: 1907-1912, 1990
21. Turman S, Coleman M, Silver R, Pasmantier M: High dose methotrexate with citrovorum factor in adult resistant lymphoma. Cancer 40: 2823-2828, 1977